[13C,2H5]-Dolutegravir

Structure only available for Premium member*.

Please log-in/register

* Detail in your account member .

  • Product number: C4671
  • CAS number: 1051375-16-6 unlabeled
  • Molecular formula: C20H19F2N3O5
  • Molecular weight: 425,33 g.mol-1
  • Min. purity: 95,00 %
  • Min. isotopic enrichment: 99% 13C, 98% 2H
  • Solubility: refer to COA
  • Stability: ≥ 1 year
  • Shipping: 24/48h for products in stock
Make a request
Product Number: C4671
Size
Qty

Description

Dolutegravir is intended for Pharmaceuticals applications. Phase III clinical trials for the treatment of HIV infection. All information about [13C,2H5]-Dolutegravir is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Related products

References

  1. Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV Pharmaceuticals 2021, 14, 12 [...]
  2. HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-ß-d-glucuronide in human plasma Journal of Pharmaceutical and Biomedical Analysis Volume 182, 15 April 2020, 113119 [...]

Recommendation